Isthmus Partners LLC Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Isthmus Partners LLC boosted its position in HCA Healthcare, Inc. (NYSE:HCA) by 0.1% in the 3rd quarter, Holdings Channel reports. The fund owned 35,973 shares of the company’s stock after purchasing an additional 35 shares during the period. HCA Healthcare makes up about 1.7% of Isthmus Partners LLC’s investment portfolio, making the stock its 19th biggest position. Isthmus Partners LLC’s holdings in HCA Healthcare were worth $14,621,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Bangor Savings Bank grew its stake in HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $28,000. GPS Wealth Strategies Group LLC boosted its holdings in shares of HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at $33,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently weighed in on HCA shares. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Royal Bank of Canada lifted their target price on shares of HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a report on Friday, August 23rd. Finally, StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $380.29.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The trade was a 21.97 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 in the last ninety days. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE:HCA opened at $325.47 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71. HCA Healthcare, Inc. has a fifty-two week low of $245.84 and a fifty-two week high of $417.14. The firm has a 50-day simple moving average of $373.42 and a 200 day simple moving average of $358.28. The company has a market cap of $82.44 billion, a PE ratio of 14.61, a P/E/G ratio of 1.25 and a beta of 1.68.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.